WPI 844 (Glipizide Extended Release 5 mg)
Pill with imprint WPI 844 is Orange, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Watson Laboratories, Inc.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 844
- WPI 844
- 5 mg
- 6.00 mm
- Prescription only
- Drug Class
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
hydroxyethyl cellulose (2000 mpa.s at 1%),
methacrylic acid - methyl methacrylate copolymer (1:1),
polyethylene glycol 400,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00591-0844||Watson Pharmaceuticals, Inc.|
|68084-0111||Amerisource Health Services|
|10370-0190 (Discontinued)||Anchen Pharmaceuticals, Inc.|
|54569-5547||A-S Medication Solutions, LLC (repackager)|
|54868-5210 (Discontinued)||Physicians Total Care Inc. (repackager)|
Related images for "WPI 844"
More about glipizide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (64)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: sulfonylureas
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.